0008

CGN Nuclear Technology Development Stock Price

Symbol: SZSE:000881Market Cap: CN¥7.4bCategory: Materials

000881 Share Price Performance

Community Fair Values

    Recent 000881 News & Updates

    No updates

    CGN Nuclear Technology Development Co., Ltd. Key Details

    CN¥5.9b

    Revenue

    CN¥5.2b

    Cost of Revenue

    CN¥726.1m

    Gross Profit

    CN¥1.1b

    Other Expenses

    -CN¥362.0m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    Aug 29, 2025
    Earnings per share (EPS)
    -0.38
    Gross Margin
    12.27%
    Net Profit Margin
    -6.12%
    Debt/Equity Ratio
    56.7%

    CGN Nuclear Technology Development Co., Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 000881

    Founded
    1993
    Employees
    4338
    CEO
    n/a
    WebsiteView website
    www.cgnnt.com.cn

    CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services. In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products. Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.

    Chinese Market Performance

    • 7 Days: -1.1%
    • 3 Months: 11.1%
    • 1 Year: 28.8%
    • Year to Date: 11.5%
    Over the last 7 days, the market has dropped 1.1%, driven by a decline of 2.4% in the Industrials sector. As for the longer term, the market has actually risen by 29% in the last year. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading